Literature DB >> 19132471

Proctocolectomy for colon cancer associated with ulcerative colitis a few months after living donor liver transplantation for primary sclerosing cholangitis: report of a case.

Takasuke Fukuhara1, Akinori Egashira, Masakazu Imamura, Toru Ikegami, Eiji Oki, Yuji Soejima, Noriaki Sadanaga, Akinobu Taketomi, Takashi Yao, Masaru Morita, Yoshihiro Kakeji, Masazumi Tsuneyoshi, Yoshihiko Maehara.   

Abstract

Colorectal cancer (CRC) frequently develops in patients with ulcerative colitis (UC). We report a case of CRC treated successfully by proctocolectomy 8 months after living donor liver transplantation (LDLT) for primary sclerosing cholangitis (PSC). The lesion was detected early, probably as a result of colonoscopic surveillance after LDLT. Thus, patients with a long history of UC, who undergo LDLT for PSC, should be followed up with regular surveillance colonoscopy. Moreover, surgery, such as radical resection of the colon and rectum should be performed without delay, even shortly after LDLT. To our knowledge, this is the first report of a patient undergoing proctocolectomy after LDLT.

Entities:  

Mesh:

Year:  2009        PMID: 19132471     DOI: 10.1007/s00595-008-3779-6

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  27 in total

1.  Colorectal cancer screening: clinical guidelines and rationale.

Authors:  S J Winawer; R H Fletcher; L Miller; F Godlee; M H Stolar; C D Mulrow; S H Woolf; S N Glick; T G Ganiats; J H Bond; L Rosen; J G Zapka; S J Olsen; F M Giardiello; J E Sisk; R Van Antwerp; C Brown-Davis; D A Marciniak; R J Mayer
Journal:  Gastroenterology       Date:  1997-02       Impact factor: 22.682

2.  Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis.

Authors:  Igor Dvorchik; Michael Subotin; A Jake Demetris; John J Fung; Thomas E Starzl; Samuel Wieand; Kareem M Abu-Elmagd
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

3.  Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.

Authors:  I W Graziadei; R H Wiesner; P J Marotta; M K Porayko; J E Hay; M R Charlton; J J Poterucha; C B Rosen; G J Gores; N F LaRusso; R A Krom
Journal:  Hepatology       Date:  1999-11       Impact factor: 17.425

4.  The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis.

Authors:  K Shetty; L Rybicki; A Brzezinski; W D Carey; B A Lashner
Journal:  Am J Gastroenterol       Date:  1999-06       Impact factor: 10.864

5.  Primary sclerosing cholangitis in Japan--analysis of 192 cases.

Authors:  H Takikawa; T Manabe
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

6.  Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.

Authors:  E V Loftus; H I Aguilar; W J Sandborn; W J Tremaine; R A Krom; A R Zinsmeister; I W Graziadei; R H Wiesner
Journal:  Hepatology       Date:  1998-03       Impact factor: 17.425

7.  Is colonoscopy alone sufficient to screen for ulcerative colitis-associated colorectal carcinoma?

Authors:  Matthias Bruewer; Christian F Krieglstein; Markus Utech; Marc Bode; Emile Rijcken; Christoph Anthoni; Mike G Laukoetter; Guido Schuermann; Norbert Senninger
Journal:  World J Surg       Date:  2003-04-28       Impact factor: 3.352

Review 8.  Colorectal cancer in idiopathic inflammatory bowel disease.

Authors:  N Harpaz; I C Talbot
Journal:  Semin Diagn Pathol       Date:  1996-11       Impact factor: 3.464

9.  Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis.

Authors:  R H Wiesner; P M Grambsch; E R Dickson; J Ludwig; R L MacCarty; E B Hunter; T R Fleming; L D Fisher; S J Beaver; N F LaRusso
Journal:  Hepatology       Date:  1989-10       Impact factor: 17.425

10.  Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases--activation of cell invasion and migration pathways.

Authors:  Kwan Man; Kevin T Ng; Chung Mau Lo; Joanna W Ho; Bai Shun Sun; Chris K Sun; Terence K Lee; Ronnie T P Poon; Sheung Tat Fan
Journal:  Liver Transpl       Date:  2007-12       Impact factor: 5.799

View more
  3 in total

1.  Neutrophil dysfunction in steroid-overdosed patients with ulcerative colitis: potential relevance of macrophage migration inhibitory factor to increased postoperative morbidity.

Authors:  Yoshiki Okita; Chikao Miki; Shigeyuki Yoshiyama; Kohei Otake; Toshimitsu Araki; Keiichi Uchida; Masato Kusunoki
Journal:  Surg Today       Date:  2011-10-04       Impact factor: 2.549

2.  The effect of liver transplantation for primary sclerosing cholangitis on disease activity in patients with inflammatory bowel disease.

Authors:  Mahmoud Mosli; Kristopher Croome; Karim Qumosani; Bandar Al-Judaibi; Melanie Beaton; Paul Marotta; Natasha Chandok
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-07

3.  Circulating CD4+CD25+ regulatory T cells in the pathobiology of ulcerative colitis and concurrent primary sclerosing cholangitis.

Authors:  Murat Kekilli; Bilge Tunc; Yavuz Beyazit; Mevlut Kurt; Ibrahim Koral Onal; Aysel Ulker; Ibrahim Celalettin Haznedaroglu
Journal:  Dig Dis Sci       Date:  2013-01-10       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.